default author photo

Romin Pajouheshnia

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

110

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Risk of Thrombosis with Thrombocytopaenia Syndrome (Tts) after Vaccination with Azd1222: A European Vac4eu Post-Authorisation Safety Study

Number of pages: 47 Posted: 07 Jul 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, Drug Safety Research Unit, affiliation not provided to SSRN, affiliation not provided to SSRN, Utrecht University - Julius Center for Health Sciences and Primary Care, Utrecht University - Julius Center for Health Sciences and Primary Care, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Agenzia Regionale di Sanità Toscana, affiliation not provided to SSRN, affiliation not provided to SSRN, National Taiwan University - National Taiwan University Hospital (NTUH), affiliation not provided to SSRN, affiliation not provided to SSRN, Drug Safety Research Unit, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Utrecht University - Julius Center for Health Sciences and Primary Care, Drug Safety Research Unit, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, McGill University, affiliation not provided to SSRN, Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, University Medical Center Utrecht - Department Datascience & Biostatistics, Utrecht University - Julius Center for Health Sciences and Primary Care, Utrecht University - Julius Center for Health Sciences and Primary Care, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 110 (640,165)

Abstract:

Loading...

COVID-19 vaccine, thrombosis with thrombocytopaenia syndrome, SARS-CoV-2, Vaccine Safety